| Literature DB >> 28959587 |
Rekhadevi Perumalla Venkata1, Rajagopal Subramanyam1.
Abstract
Consumption of repeatedly heated cooking oil (RHCO) has been a regular practice without knowing the harmful effects of use. The present study is based on the hypothesis that, heating of edible oils to their boiling points results in the formation of free radicals that cause oxidative stress and induce damage at the cellular and molecular levels. Peroxide value of heated oil, histopathological alterations, antioxidant enzyme levels and blood biochemistry were determined in Wistar rats treated with the RHCO. RHCO revealed higher peroxide value in comparison to oil that has been unheated or singly heated. Histopathological observation depicted significant damage in jejunum, colon and liver of animals that received oil heated repeatedly for 3 times. The altered antioxidant status reflects an adaptive response to oxidative stress. Alteration in the levels of these enzymes might be due to the formation of reactive oxygen species (ROS) through auto oxidation or enzyme catalyzed oxidation of electrophilic components within RHCO. Analysis of blood samples revealed elevated levels of glucose, creatinine and cholesterol with declined levels of protein and albumin in repeatedly heated cooking oil group. Hematological parameters did not reveal any statistically significant difference between treated and control groups. Results of the present study confirm that the thermal oxidation of cooking oil generates free radicals and dietary consumption of such oil results in detrimental health effects.Entities:
Keywords: Hematological parameters; Oxidative stress; Peroxide value; Repeatedly heated cooking oil
Year: 2016 PMID: 28959587 PMCID: PMC5616019 DOI: 10.1016/j.toxrep.2016.08.003
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
Fig. 1Schematic representation of experimental design.
Fig. 2Effect of treatment on the body weight of animals (Data represented as mean; n = 10; *P < 0.05).
Fig. 3Effect of treatment on the organ weight in animals (Data represented as mean; n = 10; *P < 0.05).
Fig. 4Peroxide value of oils of different heating grades (mEqO2/kg; Data represented as mean; n = 10; *P < 0.05).
Fig. 5Effect of treatment on occurrence and distribution of polyps in the colon of mice (number of polyps).
Fig. 6Histopathological representation of tissues, Control (A) and 3RHCO treated (B) colon, jejunum and liver of animals after 28 day treatment (H & E, 400X).
Inter group comparison of antioxidant enzyme levels.
| Parameter | SOD (U/mg) | GPx (U/mg) | CAT (U/mg) | MDA (nmol/g) | ||||
|---|---|---|---|---|---|---|---|---|
| Group | Liver | Colon | Liver | Colon | Liver | Colon | Liver | Colon |
| Control | 4.25 ± 0.47 | 3.23 ± 0.48 | 5.24 ± 0.41 | 2.84 ± 0⋅34 | 205.32 ± 20.80 | 200.31 ± 20⋅15 | 14.45 ± 1.14 | 13.26 ± 1⋅32 |
| UHCO: 0.1 mL | 7.27 ± 0.64 | 5.21 ± 0⋅57 | 14.17 ± 1.45 | 7.86 ± 0⋅71 | 203.85 ± 18.57 | 205.46 ± 19⋅23 | 15.72 ± 1.32 | 14.89 ± 1.41 |
| SHCO: 0.1 mL | 12.25 ± 0.84 | 7.84± 0⋅72 | 17.23 ± 1.69 | 11.16 ± 1⋅06 | 153.68 ± 14.42 | 150.24 ± 12⋅34 | 16.02 ± 1.47 | 14.21 ± 1⋅24 |
| 3RHCO: 0.1 mL | 23.86 ± 1.34 | 12.30 ± 1⋅15 | 27.18 ± 1.61 | 15.67 ± 1⋅42∗ | 137.67 ± 13.80 | 126.23 ± 10⋅26 | 28.26 ± 1⋅84 | 23.76 ± 1⋅74∗ |
Data represented as mean ± S.D. Significantly different from control at *P < 0.05; n = 10 animals per group.
Inter group comparison of blood biochemistry parameters.
| Parameter | Dose (mL) | CONTROL | UHCO | SHCO | 3RHCO |
|---|---|---|---|---|---|
| GLU (mg/dL) | 0.1 | 70.42 ± 5.87 | 70.93 ± 0.92 | 81.62 ± 1.77 | 86.30 ± 2.04 |
| 0.2 | 70.97 ± 0.71 | 82.09 ± 1.46 | 87.75 ± 1⋅71* | ||
| CRE (mg/dL) | 0.1 | 0.98 ± 0.26 | 1.29 ± 0.17 | 1.35 ± 0.28 | 1.65 ± 0.62 |
| 0.2 | 1.31 ± 0.12 | 1.43 ± 0.26 | 1.71 ± 0.91* | ||
| CHOL (mg/dL) | 0.1 | 143.06 ± 13.06 | 152.72 ± 13.64 | 165.63 ± 12.68 | 247.65 ± 14.81 |
| 0.2 | 159.14 ± 14.92 | 174.19 ± 13.60 | 249.99 ± 13.79* | ||
| PRO (mg/dL) | 0.1 | 5.15 ± 0⋅42 | 5.09 ± 1.23 | 4.83 ± 0.53 | 3.76 ± 0.43* |
| 0.2 | 4.91 ± 1.32 | 4.77 ± 0.46 | 3.57 ± 0.42 | ||
| ALB (mg/dL) | 0.1 | 4.21 ± 1⋅15 | 4.05 ± 1.12 | 2.95 ± 0.72 | 1.59 ± 0.70* |
| 0.2 | 3.08 ± 0.62 | 2.63 ± 0.75 | 1.52 ± 0.64 |
Data represented as mean ± S.D. Significantly different from control at *P < 0.05; n = 10 animals per group.
Inter group comparison of hematological parameters.
| Parameter | Dose (mL) | Control | UHCO | SHCO | 3RHCO |
|---|---|---|---|---|---|
| Haemoglobin (g/dl) | 0.1 | 12.53 ± 1.21 | 12.25 ± 1.12 | 11.75 ± 1.15 | 9.26 ± 0.94* |
| 0.2 | 11.76 ± 1.16 | 11.25 ± 1.12 | 8.01 ± 0.64 | ||
| Haematocrit (%) | 0.1 | 34.21 ± 2.98 | 33.15 ± 1.34 | 31.26 ± 2.61 | 25.21 ± 1.26* |
| 0.2 | 32.18 ± 1.36 | 30.23 ± 2.75 | 22.85 ± 1.27 | ||
| Total erythrocyte count (x106/μl) | 0.1 | 3.91 ± 1.27 | 3.75 ± 0.37 | 3.21 ± 0.36 | 1.75 ± 0.17* |
| 0.2 | 3.19 ± 0.31 | 3.21 ± 0.35 | 1.55 ± 0.14 | ||
| Total leukocyte count (x103/μL) | 0.1 | 6.97 ± 0.63 | 6.85 ± 0.67 | 6.23 ± 0.53 | 3.01 ± 0.31 |
| 0.2 | 6.45 ± 0.65 | 6.75 ± 0.57 | 3.26 ± 0.36* | ||
| Mean corpuscular volume (pg) | 0.1 | 26.12 ± 0.87 | 25.94 ± 1.24 | 22.23 ± 1.23 | 19.75 ± 1.15* |
| 0.2 | 23.74 ± 1.26 | 21.27 ± 1.21 | 17.52 ± 1.21 |
Data represented as mean ± S.D. Significantly different from control at *P < 0.05; n = 10 animals per group.